Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy

Phase III double-blind comparison of int

Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy

✍ George W. Sledge Jr.; Lawrence Einhorn; Catherine Nag; Karen House 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Background. Ondansetron hydrochloride is a selective serotonin subtype 3 (5HTJ receptor antagonist that has been shown to be an effective antiemetic in patients receiving cisplatin chemotherapy. Methods. This double-blind study compared the safety and efficacy of intravenous ondansetron with metocl